Skip to main content
. Author manuscript; available in PMC: 2014 Apr 18.
Published in final edited form as: J Alzheimers Dis. 2011;23(3):471–489. doi: 10.3233/JAD-2010-101218

Fig. 4.

Fig. 4

DSP-4 administration resulted in a long-term NE depletion. HPLC analysis of monamines showed reduced NE levels in DSP-4 treated mice regardless of genotype, with 50% reductions in the frontal cortex and cerebellum and a 75% loss in the hippocampus. DSP-4 did not alter levels of other monoamines, such as serotonin (5-HT), dopamine, or their metabolites (data not shown).